Frank Arnone is a partner in the Business Law Group at Cassels and serves as Co-Chair of the firm’s Private Equity Group. Frank’s practice emphasizes domestic and cross-border mergers and acquisitions and corporate finance for a wide variety of issuer, underwriter and private equity clients. Frank offers extensive experience working on complex transactions in a wide range of industry sectors. He also provides ongoing advice on securities law, stock exchange compliance and corporate governance matters. Frank has written extensively on a wide variety of private equity, corporate finance and securities topics including corporate governance, and is a contributing editor of Federated Press’ Corporate Financing Journal.
Frank’s representative work includes having acted for:
- Investindustrial on the Canadian aspects of its acquisition of Jacuzzi Brands
- The underwriters in an offering by First Quantum Minerals Ltd. of $1.5 billion of Senior Notes due 2024 and Senior Notes due 2026
- Luminate Capital in its investment in Conexiom in support of its global growth strategy
- Bunker Hill Capital on the sale of its portfolio company Rizing to One Equity Partners
SK Capital on its US$1 billion acquisition of the fire safety and oil additives business of Israel Chemicals Ltd.
Frank was previously a Vice-Chair and member of the Board of Directors and Nominating & Governance Committee of the Canadian Centre for Ethics and Corporate Policy. He also served as a member of the Board of Directors of Muskoka Algonquin Healthcare, Chair of the Governance Committee and a member of the Quality & Patient Safety Committee. Prior to joining Cassels, Frank was a partner at another national firm where he headed the Securities Group and the Private Equity Group.